RxDoctor Payments Data

Jeremy Hopersberger, PA

Physician Assistant · Camp Hill, PANPI 1003467572

Payments from drug & device makers

$3,189in general payments, 2019–2025

Across 214 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$941
  • Lilly USA, LLC$322
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$316
  • Collegium Pharmaceutical, Inc.$287
  • Teva Pharmaceuticals USA, Inc.$268
  • Biohaven Pharmaceutical Holding Company Ltd.$193
  • plus $861 from 16 others

What the payments were for

  • Food & beverage$3,189100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,189 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$18,093
Medicare patients
112
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin24$33,664
FarxigaDapagliflozin Propanediol25$32,831
TrulicityDulaglutide24$26,634
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$19,243
SymbicortBudesonide/Formoterol Fumarate18$4,016
Rosuvastatin Calcium47$1,106
Ventolin HfaAlbuterol Sulfate13$755
Atorvastatin Calcium106$744
Losartan Potassium53$677
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$668
Gabapentin37$621
Sucralfate12$573
Albuterol Sulfate HfaAlbuterol Sulfate25$510
Omeprazole37$500
Levothyroxine Sodium35$492

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$105$36,84743 claims
Lilly USA, LLCTrulicity$322$26,63424 claims
GSKTrelegy Ellipta$19$19,24330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Camp Hill

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →